Canine Cognitive Dysfunction (CCD), often referred to as “dog Alzheimer’s,” is a prevalent and progressive neurobehavioral syndrome affecting senior and geriatric dogs. CCD is not simply “old age” but a recognizable disease process analogous to Alzheimer’s disease in humans. It results from age-related neurodegenerative changes, including the accumulation of \beta-amyloid plaques and cerebral atrophy, leading to impaired cognitive function.
CCD is very common, with the following signs often seen:
-
Disorientation (spatial and temporal): Pacing aimlessly, getting stuck in corners, staring blankly, or failing to recognize familiar people/places.
-
Interactions (altered): Reduced interest in play or greeting, increased irritability, or increased dependence/clinginess.
-
Sleep-Wake Cycle Alterations: Restlessness or pacing at night, excessive daytime sleeping.
-
House-soiling: Accidents indoors despite being reliably house-trained.
-
Activity Changes: Decreased or increased purpose-less activity (e.g., compulsive licking, pacing).
Management strategies typically involve a multimodal approach:
-
Pharmaceuticals: Use of selegiline (a monoamine oxidase B inhibitor) is approved to help manage symptoms. Other supportive medications, such as S-adenosylmethionine (SAMe) or specific anxiolytics, may be prescribed based on the dog’s primary symptoms.
-
Nutritional Support: Diets enriched with antioxidants (e.g. medium-chain triglycerides (MCTs) have been shown to provide an alternative energy source for the aging brain and improve cognitive function in some dogs.
-
Environmental Enrichment: Maintaining a predictable routine, using environmental aids (e.g., nightlights, ramps), and providing gentle, consistent cognitive exercise (e.g., puzzle toys, short training sessions) are essential.
Please note that I am unable to answer veterinary questions in comments. If you have questions or concerns about your pet's health it is always better to contact your vet.